As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...